LENZ Therapeutics, Inc. (LENZ)

Corporate Overview

LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision, proudly based in San Diego. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia.

Our Leadership

Latest Financial Results

Q1 2024

Quarter Ended Mar 31, 2024

Earnings Release PDF

Earnings Webcast

10-Q PDF

XBRL

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2023

Latest News

Jul 15, 2024 • 8:00 AM EDT

LENZ Therapeutics Announces $30 Million Investment from Ridgeback Capital

View Press Release View All News

Email Alerts

Get the latest news and reports delivered right to your inbox.

IR Contacts

Corporate

LENZ Therapeutics, Inc.
201 Lomas Santa Fe Drive
Suite 300
Solana Beach, CA 92075
T: 858-925-7000
contact@lenz-tx.com

Investor Relations

LENZ Therapeutics
IR@LENZ-Tx.com

Stern Investor Relations, Inc.
Janhavi Mohite
janhavi.mohite@sternir.com

Transfer Agent

Equiniti Trust Company, LLC
48 Wall Street
New York, NY 10005
T: 800-937-5449